1. Controversies and prospects about microglia in maternal immune activation models for neurodevelopmental disorders.
- Author
-
Smolders S, Notter T, Smolders SMT, Rigo JM, and Brône B
- Subjects
- Animals, Behavior, Animal physiology, Brain immunology, Disease Models, Animal, Female, Immune System drug effects, Lipopolysaccharides pharmacology, Mice, Microglia drug effects, Microglia metabolism, Mothers, Neurodevelopmental Disorders physiopathology, Poly I-C pharmacology, Pregnancy, Pregnancy Complications, Infectious immunology, Pregnancy Complications, Infectious metabolism, Rats, Microglia physiology, Neurodevelopmental Disorders immunology, Prenatal Exposure Delayed Effects immunology
- Abstract
Activation of the maternal immune system during pregnancy is a well-established risk factor for neuropsychiatric disease in the offspring, yet, the underlying mechanisms leading to altered brain function remain largely undefined. Microglia, the resident immune cells of the brain, are key to adequate development of the central nervous system (CNS), and are prime candidates to mediate maternal immune activation (MIA)-induced brain abnormalities. As such, the effects of MIA on the immunological phenotype of microglia has been widely investigated. However, contradicting results due to differences in read-out and methodological approaches impede final conclusions on MIA-induced microglial alterations. The aim of this review is to critically discuss the evidence for an activated microglial phenotype upon MIA., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF